Viewing Study NCT01263860


Ignite Creation Date: 2025-12-25 @ 2:08 AM
Ignite Modification Date: 2025-12-26 @ 12:35 AM
Study NCT ID: NCT01263860
Status: COMPLETED
Last Update Posted: 2014-11-18
First Post: 2010-12-20
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Randomized Trial of 24-Week Versus 48-Week Courses of Peginterferon Plus Ribavirin for HCV Genotype-6 Patients
Sponsor: Third Affiliated Hospital, Sun Yat-Sen University
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module